Its approach is based on a patented technology that enables the targeted neutralization of disease-relevant mechanisms within the oral microbiome. This technology originated from an EU-funded project involving numerous international partners, including the Fraunhofer Institute for Cell Therapy and Immunology IZI. The VORSPRUNG Business Prize, awarded by the East German Economic Forum (OWF), recognizes companies that demonstrate outstanding innovation, a forward-looking strategy, and sustainable growth. The award ceremony took place on May 5 at the Federal Ministry of Finance in Berlin.